id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1977-N-0356-0019,FDA,FDA-1977-N-0356,Letter from K & L Gates to FDA CDER,Other,Letter(s),2020-07-21T04:00:00Z,2020,7,2020-07-21T04:00:00Z,,2020-07-21T14:17:11Z,,0,0,090000648478c167
FDA-1977-N-0356-0022,FDA,FDA-1977-N-0356,"Letter from Lumara Health, AMAG Pharmaceuticals",Other,Letter(s),2020-07-21T04:00:00Z,2020,7,2020-07-21T04:00:00Z,,2020-07-21T14:23:49Z,,0,0,090000648478cf79
FDA-1977-N-0356-0020,FDA,FDA-1977-N-0356,Letter from K & L Gates to FDA CDER,Other,Letter(s),2020-07-21T04:00:00Z,2020,7,2020-07-21T04:00:00Z,,2020-07-21T14:19:16Z,,0,0,090000648478c168
FDA-1977-N-0356-0021,FDA,FDA-1977-N-0356,Letter from KV Pharmaceutical to FDA CDER,Other,Letter(s),2020-07-21T04:00:00Z,2020,7,2020-07-21T04:00:00Z,,2020-07-21T14:21:33Z,,0,0,090000648478c169
FDA-1977-N-0356-0018,FDA,FDA-1977-N-0356,"Letter from Time-Cap Labs, Inc. (King & Spalding) to FDA",Other,Letter(s),2020-01-13T05:00:00Z,2020,1,2020-01-13T05:00:00Z,,2020-01-13T21:07:32Z,,0,0,090000648428a8cd